Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Secondary Cervical Cancer Prevention of Vulnerable Women With Human Papillomavirus (HPV) and Human Immunodeficiency Virus (HIV) Co-infection in India

NCT07209917 is registered in ClinicalTrials.gov with University of California, Irvine as lead sponsor.

NCT NCT07209917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07209917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Secondary Cervical Cancer Prevention of Vulnerable Women With Human Papillomavirus (HPV) and Human Immunodeficiency Virus (HIV) Co-infection in India
Lead sponsor
University of California, Irvine
Phase
Not applicable
Overall status
Recruiting
Start date
February 1, 2026
Completion date
April 30, 2029
Enrollment
348 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, human immunodeficiency virus (hiv) infection, human papillomavirus (hpv) infection